Title : Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.

Pub. Date : 2022 Mar 7

PMID : 35250023






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib. AZD 6244 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens